Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Elacestrant

🥰Excellent
Catalog No. T13674Cas No. 722533-56-4
Alias RAD1901

Elacestrant (RAD1901) with IC50s of 48 and 870 nM for ERα and ERβ, respectively.Elacestrant  is an orally available selective estrogen receptor degrader .

Elacestrant

Elacestrant

🥰Excellent
Purity: 98.92%
Catalog No. T13674Alias RAD1901Cas No. 722533-56-4
Elacestrant (RAD1901) with IC50s of 48 and 870 nM for ERα and ERβ, respectively.Elacestrant  is an orally available selective estrogen receptor degrader .
Pack SizePriceAvailabilityQuantity
1 mg$147In Stock
5 mg$347In Stock
10 mg$497In Stock
25 mg$793In Stock
50 mg$1,130In Stock
100 mg$1,520In Stock
1 mL x 10 mM (in DMSO)$388In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Elacestrant"

Select Batch
Purity:98.92%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Elacestrant (RAD1901) with IC50s of 48 and 870 nM for ERα and ERβ, respectively.Elacestrant  is an orally available selective estrogen receptor degrader .
Targets&IC50
ERβ:870 nM , ERα:48 nM
In vitro
Elacestrant treatment exhibits dose-dependent inhibition of ERα expression, with an EC50 of 0.6 nM.Treatment of ER-positive MCF-7 cells with E2 results in a potent and dose-dependent increase in proliferation, with an EC50 of 4 pM.Treatment of cells with Elacestrant in the presence of 10 pM E2 resultsin a dose-dependent decrease in proliferation, with an IC50 value of 4.2 nM.Elacestrant selectively binds to and degrades the ER and is a potent antagonist of ER-positive breast cancer cell proliferation.
In vivo
Elacestrant produces a robust and profound inhibition of tumor growth in MCF-7 xenograft models.Elacestrant preserves ovariectomy-induced bone loss and preventes the uterotropic effects of E2.Elacestrant-treated animals survived longer than those treated with either control or fulvestrant.
AliasRAD1901
Chemical Properties
Molecular Weight458.63
FormulaC30H38N2O2
Cas No.722533-56-4
SmilesCCNCCc1ccc(CN(CC)c2cc(OC)ccc2[C@@H]2CCc3cc(O)ccc3C2)cc1
Relative Density.1.111 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 60 mg/ml (130.82 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.1804 mL10.9020 mL21.8041 mL109.0203 mL
5 mM0.4361 mL2.1804 mL4.3608 mL21.8041 mL
10 mM0.2180 mL1.0902 mL2.1804 mL10.9020 mL
20 mM0.1090 mL0.5451 mL1.0902 mL5.4510 mL
50 mM0.0436 mL0.2180 mL0.4361 mL2.1804 mL
100 mM0.0218 mL0.1090 mL0.2180 mL1.0902 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Elacestrant | purchase Elacestrant | Elacestrant cost | order Elacestrant | Elacestrant chemical structure | Elacestrant in vivo | Elacestrant in vitro | Elacestrant formula | Elacestrant molecular weight